The Urological Oncology group in the Faculty of Health and Medical Sciences at the University of Surrey has 24 members with an extensive range of experience, from laboratory-based projects involving basic cell and molecular biology to the delivery of clinical trials in human cancers. The group is supported by the infrastructure required to undertake complex, multi-disciplinary studies. A particular strength of the team is the acquisition of patient samples (after suitable ethical approval) and this is partly due to the strong links with the local Royal Surrey County Hospital and the neighbouring St Luke’s Cancer Centre.
The group has an established track record for the supervision of MD and PhD students and has published an impressive 110 original peer reviewed papers since arriving at Surrey.
The group has an active portfolio of phase I, II and III trials in new cancer therapies (small molecule inhibitors, cancer vaccine, viral and gene therapy).
The oncology group has received support from the Prostate Project, Breast Cancer Campaign, the Skin Cancer Research Fund, the June Hancock Mesothelioma Research Foundation and the British Lung Foundation.